Volume : 09, Issue : 02, February – 2022
Title:
02.DESIGN AND DEVLEOPMENT OF LYOPHILIZATION CYCLE FOR PARECOXIB POWDER FOR SOLUTION FOR INJECTION 40 MG
Authors :
*Kabirdas B. Ghorpade, Rohit Bhalke, Sharda M. Shinde, Ujwal Hawelikar
Abstract :
Solution stability of the drug is the major challenge of the parmaceutical industries. Lyophilization is also known as freeze drying is the subjectof current research for most of the scientists to overcome these challenges.Lyophilization consists of three steps freezing, primary drying and secondary drying.Freezing is the pre requisite step for the primary drying where all the unbound water turns into freeze concentrate and water molecules removed by sublimation. Primary drying is the longest step of the lyophiization.In secondary drying the bound water which is associated with the drug molecules can be removed by the desorption by the application of heat and vaccum.The objective of study is Parecoxib different formulations used to Optimization of Lyophilization cycles and the main focus is to minimize consistently drying times, while maintaining constant Parecoxib Powder for Solution for Injection product quality.
Methods: The various formulations were studied for thermal events by DSC technique and the determination of the critical events by FDM analysis. By collaborated observations from these studies the lyophilzation cycles were developed and studied.
Results: The data obtained from DSC and FDM analysis of drug solution was used to determine set temperature to be used during freezing, primary drying and secondary drying set temperatures. The set vacuum for the chamber during the primary drying and secondary drying was determined from the operation manual of Lyodryer LSI Freeze dryer. The optimized cycle was about 66 hrs used for better productivity. Evaluated the lyophilized product for water content and assay and x ray diffraction. Pharmaceutical equivalence study was conducted for Parecoxib powder for solution for injection with innovator product (Dynastat®).
Conclusion: Finally concluded that the present developed lyo cycle was used to execute the Parecoxib Powder for Solution for Injection product.
Keywords: Parecoxib, Lyophilization cycle, Impedance, FDM analysis,DSC Analysis, Poor thermal stability, Freezing, Primary drying, Secondary drying, X-Ray diffraction.
Cite This Article:
Please cite this article in press Kabirdas B. Ghorpade et al, Design And Development Of Lyophilization Cycle For Parecoxib Powder For Solution For Injection 40 Mg., Indo Am. J. P. Sci, 2022; 09(02).
Number of Downloads : 10
References:
1. https://pubchem.ncbi.nlm.nih.gov/compound/Parecoxib-sodium#:~:text=Parecoxib%20Sodium%20is%20a%20water,%2C%20analgesic%2C%20and%20antipyretic%20activities.
2. Thomas W. Patapoff and David E. Overcashier “The importance of freezing on lyophilization cycle development” Biopharm 2002; 3: 16-22
3. Rey L, May JC, Editor “Freeze drying/lyophilization of pharmaceutical and biological products” Marcel Dekker Inc New York 2004; 1-32
4. B. Nuijon, M. Bouma, H. Talsma, C. Manada, J.M Jimcno, L. Lopez-Lazaro “Development of a lyophilized Parenteral Pharmaceutical formulation of the Investigational polypeptide Marine anti-cancer agent Kahalalide” F.Drug.Dev.Ind. pharm 2001; 27(8): 767-80
5. Xiang J et al Investigation of freeze-drying sublimation rates using a freeze-drying microbalance technique, Int. J of Pharma 2004; 279 : 95-105
6. Rey L, May JC, Editor “Freeze drying/lyophilization of pharmaceutical and biological products” Marcel Dekker Inc New York 2004 : 1-32
7. Wallen AJ, Van ocker SH, Sinacola JR, Phillips BR “The effect of loading process on product collapse during large scale lyophilization” Pharma Sci 2008
8. Searles JA, Carpenter JF, Randolph TW. The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. J Pharm Sci. 2001; 90(7): 860–71.
9. Flink JM. and Knudsen, An Introduction to Freeze Drying. Strandberg Bogtryk Offset, Denmark. 1983
10. Nail SL. et al. Fundamentals of freeze-drying. Development and Manufacture of Protein Pharmaceuticals.Marcel Dekker, 2002; 281–360.
11. . Her, L.-M.; Nail, S.L. Measurement of glass transition temperatures of freezeconcentrated solutes by differential scanning calorimetry, Pharm Res., 1994, 11, 54- 59.
12. Skrabanja, A.T.P.; De Meere, A.L.J.; De Ruiter, R.A.; Van Den Oelelaar, P.J. M. Lyophilization of biotechnology products, PDA J. Pharm. Sci.& Technol., 1994, 48, 311-317.
13. . Gatlin, L.; Deluca, P. A study of the phase transitions in frozen antibiotic solutions by differential scanning calorimetry, J. of the Parenteral Drug Association, 1980, 34, 398-408.
14. Jeff SJ. Basic Cycle Development Techniques for Lyophilized Products. 2009; 35: 126- 128.
15. Adams GD, Irons LI. Some implications of structural collapse during freeze drying using Erwinia caratovora l-asparaginase as a model. J Chem Biotechnol, 1993; 58: 71– 76.
16. Pikal, M.J.; Shah S. The collapse temperature in freeze drying: dependence on measurement methodology and rate of water removal from the glassy phase. Int J Pharm, 1990, 62, 165-186.
17. Meister, E.; Gieseler, H. Freeze-dry microscopy of protein/sugar mixtures: Drying behavior, interpretation of collapse temperatures and a comparison to corresponding glass transition Data, J Pharm Sci , 2009, 98, 3072 – 3087.
18. Swarbrick P, Teagarden DL, Jennings T. The Freezing Process, in: Lyophilization, Introduction and Basic Principles, Interpharm Press, Englewood, USA. 1999; 154- 178.
19. . Roy M., Pikal MJ, Process control in freeze drying: determination of the end point of sublimation drying by an electronic moisture sensor. J Parenter Sci Technol. 1989; 43(2): 60.
20. Bardat A, Biguet J, Chatenet E, Courteille F, Moisture measurement: a new method for monitoring freeze-drying cycles. J Parenter Sci Technol. 1993; 47(6): 293–299.
21. Luyet, B.J. Phase transitions encountered in the rapid freezing of aqueous solutions, Annals of the New York Academy of Sciences, 1965, 125, 502-521.